SBIR PHASE III - REVERSING IMMUNE DYSREGULATION DURING SPACEFLIGHT MISSIONS
$2,234,767
| Recipient | SACHI BIOWORKS, INC. UEI NTKPGKZLXPC1 |
|---|---|
| Award ID | 80NSSC24CA006 |
| Award amount | $2,234,767 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | National Aeronautics and Space Administration — National Aeronautics and Space Administration |
| NAICS | 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| PSC | AJ14 |
| Start date | Mar 18, 2024 |
| End date | Mar 17, 2026 |
| Place of performance | LOUISVILLE, CO |
| Record updated | Jan 9, 2026 |
View the official award record
More awards won by SACHI BIOWORKS, INC.
E014042 SBIR PHASE III RAPID, LOW-COST NANOLIGOMERTM BASED DRUG-DISCOVERY IN SPACE
National Aeronautics and Space Administration · $9,595,716 · Jul 10, 2023
E014042 SBIR PHASE II REVERSING IMMUNE DYSREGULATION DURING SPACEFLIGHT MISSIONS
National Aeronautics and Space Administration · $1,599,984 · Apr 14, 2022
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids